Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 2,675.00
-80.00 (-2.90%)
Aug 12, 2026, 2:40 PM KST
Genexine Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 5,808 | 4,427 | 16,139 | 36,828 | 18,543 | 11,303 |
Revenue Growth | -3.50% | -72.57% | -56.18% | 98.61% | 64.06% | 80.80% |
Gross Profit Gross Profit Growth | -196.75 | 302.04 | 11,248 | 30,743 | 9,759 | 6,699 |
Operating Income Operating Income Growth | -43,184 | -41,928 | -33,680 | -19,099 | -39,151 | -44,573 |
Net Income Net Income Growth | -54,525 | -66,874 | -55,974 | -48,042 | 27,570 | -16,509 |
Earnings Per Share EPS Growth | -1320.62 | -1652.14 | -1715.00 | -1482.55 | 671.51 | -595.38 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
South Korea South Korea Growth | 1,479 | 1,724 | 1,700 | 2,898 | 9,874 | 11,303 |
Asia Asia Growth | - | 25.01 | 9,954 | 29,917 | 689.79 | - |
Americas Americas Growth | 3,836 | 2,677 | 4,486 | 4,013 | 7,979 | - |
Total Total Growth | 5,808 | 4,427 | 16,139 | 36,828 | 18,543 | 11,303 |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 52,501 | 64,482 | 21,942 | 27,796 | 6,714 | 82,516 |
Total Debt Total Debt Growth | 68,665 | 67,427 | 84,083 | 52,218 | 27,155 | 39,377 |
Net Cash (Debt) Net Cash Growth | -16,165 | -2,945 | -62,141 | -24,423 | -20,441 | 43,139 |
Net Cash Growth | - | - | - | - | - | 429.29% |
Net Cash Per Share Net Cash Per Share Growth | -391.51 | -72.76 | -1903.83 | -753.67 | -644.31 | 1555.73 |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -34,024 | -38,055 | -39,800 | -12,745 | -22,691 | -41,572 |
Capital Expenditures CapEx Growth | -8,278 | -7,273 | -31,747 | -56,433 | -22,208 | -3,962 |
Free Cash Flow Free Cash Flow Growth | -42,303 | -45,328 | -71,547 | -69,178 | -44,899 | -45,533 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | -3.39% | 6.82% | 69.69% | 83.48% | 52.63% | 59.27% |
Operating Margin | -743.54% | -947.19% | -208.69% | -51.86% | -211.13% | -394.34% |
Pretax Margin | -938.51% | -1510.41% | -352.13% | -132.71% | 148.49% | -146.06% |
Profit Margin | -938.81% | -1510.71% | -346.82% | -130.45% | 148.68% | -146.06% |
FCF Margin | -728.36% | -1023.98% | -443.31% | -187.84% | -242.13% | -402.84% |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PE Ratio | - | - | - | - | 111.35 | - |
PS Ratio | 21.57 | 92.70 | 29.14 | 39.62 | 165.55 | 131.39 |